{"id":521459,"date":"2021-08-02T16:04:27","date_gmt":"2021-08-02T20:04:27","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/"},"modified":"2021-08-02T16:04:27","modified_gmt":"2021-08-02T20:04:27","slug":"kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/","title":{"rendered":"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">HAMILTON, Bermuda, Aug.  02, 2021  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=gkN3yI8gLhJbd-FLYStHXjhf9XmVXQUxTJTPDDMGcNfESzB8JacrBKBMhtBTn-yFgA0S6umD02llutnD13S-iPay_6DjLf9GdiopeDVkSI8=\" rel=\"nofollow noopener\" target=\"_blank\">Kiniksa Pharmaceuticals, Ltd.<\/a> (Nasdaq: KNSA) announced today that it will present at\u00a0the 2021 Wedbush PacGrow Healthcare Conference on\u00a0Tuesday, August 10, 2021 at 2:55 p.m. Eastern Time.<\/p>\n<p>A live webcast of Kiniksa\u2019s presentation will be accessible through the Investors &amp; Media section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v74U60249DHfVBRNMY87phjYl3Ukl-kmWL5ACupTdgh18v2sGI57ZUSKHVdvCuY8UIuKcI7JrfxUkb4vZ4VEBA==\" rel=\"nofollow noopener\" target=\"_blank\">www.kiniksa.com<\/a>. A replay of the webcast will be available on Kiniksa\u2019s website for 14 days following the conference.<\/p>\n<p>\n        <strong>About Kiniksa<\/strong><br \/>\n        <br \/>Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa\u2019s portfolio of assets, ARCALYST<sup>\u00ae <\/sup>(rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=v74U60249DHfVBRNMY87ptWUISAcv0LUmqaS0yXLclke37bKnfhCZqIAf6f5qOvgVPhA5vn8cNcxmzpXuraD0w==\" rel=\"nofollow noopener\" target=\"_blank\">www.kiniksa.com<\/a>.<\/p>\n<p>ARCALYST<sup>\u00ae<\/sup>\u00a0is a registered trademark of\u00a0Regeneron Pharmaceuticals,\u00a0Inc.<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"vertical-align: top\">\n            <strong><br \/>\n              <em>Every Second Counts!\u2122<\/em><br \/>\n            <\/strong><\/p>\n<p>            <strong>Kiniksa Investor and Media Contact<\/strong><br \/>\n            <br \/>Rachel Frank<br \/>(339) 970-9437<br \/><a href=\"mailto:rfrank@kiniksa.com\" rel=\"nofollow noopener\" target=\"_blank\">rfrank@kiniksa.com<\/a><\/td>\n<td style=\"vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<\/table>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/794a0148-f476-4090-9faa-21eac507fa9c\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HAMILTON, Bermuda, Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at\u00a0the 2021 Wedbush PacGrow Healthcare Conference on\u00a0Tuesday, August 10, 2021 at 2:55 p.m. Eastern Time. A live webcast of Kiniksa\u2019s presentation will be accessible through the Investors &amp; Media section of the company\u2019s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa\u2019s website for 14 days following the conference. About Kiniksa Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa\u2019s portfolio of assets, ARCALYST\u00ae (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-521459","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"HAMILTON, Bermuda, Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at\u00a0the 2021 Wedbush PacGrow Healthcare Conference on\u00a0Tuesday, August 10, 2021 at 2:55 p.m. Eastern Time. A live webcast of Kiniksa\u2019s presentation will be accessible through the Investors &amp; Media section of the company\u2019s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa\u2019s website for 14 days following the conference. About Kiniksa Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa\u2019s portfolio of assets, ARCALYST\u00ae (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved &hellip; Continue reading &quot;Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-08-02T20:04:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference\",\"datePublished\":\"2021-08-02T20:04:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/\"},\"wordCount\":182,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/\",\"name\":\"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=\",\"datePublished\":\"2021-08-02T20:04:27+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/","og_locale":"en_US","og_type":"article","og_title":"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference - Market Newsdesk","og_description":"HAMILTON, Bermuda, Aug. 02, 2021 (GLOBE NEWSWIRE) &#8212; Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will present at\u00a0the 2021 Wedbush PacGrow Healthcare Conference on\u00a0Tuesday, August 10, 2021 at 2:55 p.m. Eastern Time. A live webcast of Kiniksa\u2019s presentation will be accessible through the Investors &amp; Media section of the company\u2019s website at www.kiniksa.com. A replay of the webcast will be available on Kiniksa\u2019s website for 14 days following the conference. About Kiniksa Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksa\u2019s portfolio of assets, ARCALYST\u00ae (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved &hellip; Continue reading \"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2021-08-02T20:04:27+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference","datePublished":"2021-08-02T20:04:27+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/"},"wordCount":182,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/","name":"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=","datePublished":"2021-08-02T20:04:27+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODMwMTA5MyM0MzM2Nzg1IzIwOTc3ODY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/kiniksa-pharmaceuticals-to-present-at-2021-wedbush-pacgrow-healthcare-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521459","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=521459"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/521459\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=521459"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=521459"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=521459"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}